The following will focus on examining the mTOR pathways that are positively (PI3K/AKT/mTOR, MAPK) and negatively (p53, AMPK) regulated that are closely associated with GC, with the objective of providing insights into targeting and regulating tumor-associated autophagy signaling for optimal therapeutic outcomes. The gene discussed is MTOR; the disease is gastric cancer.